Clinical TrialsSearch results
Number of results: 199
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- LIVES Study Extention
- hypercholesterolemia
- LIVES Study Extension advisory committee
- 2007-09-18
Other
- The high-risk strategy by lifestyle modification (HISLIM) study
- hypercholesterolemia,hypertension,smoking
- HISLIM study research group
- 2005-10-01
Other
- Assessment of clinical usefulness in CKD patients with atorvastatin trial (ASUCA Trial)
- Hyperlipidemia with Chronic Kidney Disease (CKD)
- Kyoto University Graduate School of Medicine
- 2009-03-17
Other
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Hypertension
- EBM Collaborating Research Center in Kyoto University
- 2005-10-30
Other
- Hypertesive Patient in Hokuriku area research of Candesartan
- hypertension
- Ishikawa Internal Medicine Association
- 2009-01-28
Other
- The High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study
- hypertension, dyslipidemia, glucose intolerance and smoking
- HIPOP-OHP Study Research group
- 2005-09-12
Other
- Japanese evaluation between FormuLa of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study
- Hypertensive patients with albuminuria and diabetes (diabetic nephropathy)
- J-FLAG Study Group
- 2009-01-29
Recruiting
- COmbination Strategy on renal function of the benidipine or diuretics treatMent with RAS inhibitOrs in CKD hypertensive population
- Hypertensive patients with albuminuria under the treatment of the inhibitor of the renin-angiotension system (RAS)
- COSMO-CKD Study Group
- 2009-07-01
Recruiting
- A Phase 3, multicenter, open label, randomized, non-comparative two-arm study of ivosidenib monotherapy (IVO) and azacitidine monotherapy (AZA) in adult patients with hypomethylating agent (HMA) naive myelodysplastic syndromes (MDS) with an IDH1 mutation (PyramIDH study)
- hypomethylating agent (HMA) naive myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1
- Patel Prapti
- 2024-12-10